Pharma R&D & Clinical Services · Indirect
Monitoring · monthly
Procurement Category Intelligence

Regulatory Affairs Consulting

PDF
Overview
Market size
8.9 billion
global, USD
CAGR
5.3%
base to forecast
Buyer power
-2.4
supplier-favoured
Suppliers
7
tracked players
Signals
12
monitored

Risk Exceptions

3
11China17United States1United Kingdom1Brazil1Saudi Arabia
5 countries · 0 lanes from 0 sourced statements

Buyer Power Score

-50+5
Negotiating position for this category, scored from supplier-favoured to buyer-favoured
-2.4 ⓘ
Equal to a supplier-favoured market into 2026 cover

Recommended stance. Lock 18-month framework agreements now

Catalysts & Deadlines

3
12 SignalsLive in the feed
12 ActionsRecommended
0 HighSeverity

Supplier Intelligence

7See all

Industry News

3

Related categories

Contract Research Organizations - PreclinicalContract Research Organizations - ClinicalClinical Trial Site ManagementClinical Data Management ServicesClinical Trial Patient RecruitmentPharmacovigilance ServicesDrug Safety MonitoringFDA Submission Support